MDGL Competitors & Alternatives
Compare Madrigal Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
MDGL
Main Stock$432.60
Tradestie Score
55
Market Cap
$10.01B
Revenue Growth
0.5%
Analyst Upside
+59.3%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EXEL
Exelixis Inc
|
$70.58
|
$11.09B | 21.5 | 32 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$41.19
|
$10.76B | - | 43 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$250.83
|
$10.74B | - | 48 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$57.13
|
$10.53B | - | 51 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$28.19
|
$10.49B | - | 45 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$78.67
|
$10.22B | - | 41 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.82
|
$9.33B | 66.8 | 59 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$73.35
|
$8.88B | 54.8 | 56 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$102.98
|
$8.77B | 25.9 | 54 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$193.06
|
$8.57B | - | 52 | Compare |
More MDGL Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry